anticoagulants and hemostatic agents Flashcards
what breaks down clot formation
fibrinolysis
what factor activates Factor I (Fibrinogen) to form a clot
factor II (thrombin)
what is the intrinsic clotting pathway
what patients are candidates for Anticaogulants
Hypercoaguable/Thromboembolic states
* cats w/ hypertrophic CM
* dogs w/ immune mediated hemolytic anemia
* cushing’s dz
* acute phase inflammation
* protein losing nephropathy
what patients are candidates for hemostatic agents
Hypocoaguable states
* post Sx, trauma, intoxication
* genetic bleeding diatheses
* liver intoxication/failure
* disseminated intravascular coagulopathy
What is the indicated use for Warfarin sodium
prophylactic txt of thrombotic conditions
use is HIGLY CONTROVERSIAL
what it the MOA of Warfarin
blocks recycling of gamma glutamyl carboxylase vit k (oxidized) back into its reduced form
recycling is caused by vit k epoxide reductase
Warfarin toxicity
- Narrow TI
- fatal hemorrhage associated w/ anemia
- hematomas can form in any system
Warfarin use requires the VERY FREQUENT monitoring of what
prothrombin time
indicated use of Vitamin K1
- rodenticide toxicity and moldy sweet clover
- prolonged sulfonamide txt of birds for coccidiosis
why won’t vitamin K1 work in patients w/ chronic liver failure
the liver synthesizes coagulation factors
how does vitamin K1 work
gets conjugated to newly synthesized gamma glutamyl carboxylase in the liver by dI-diaphorase (makes new gamma glutamyl carboxylase)
Vit K1 administration
PO in dogs w/ fatty meal
IM or SC in food animals
therapeutic effects occur 6-12 hrs post admin
toxicity/adverse effects of Vit K
ANAPHYLAXIS
Heparin soidum vs Enoxaparin Na & Dalteparin Na
Heparin is a large glycosaminoglycan compared to Enoxaparin & Dalteparin which are low molecular weight heparin fractions
Heparin has a tail that allows for the shut down of both Factor Xa and thrombin but the other drugs lack a tail and can only shut down factor Xa
admin of heparin
IV
SC if LMWH (enoxaparin / dalteparin)
metabolism of heparin
liver & reticuloendothelial system/macrophages
heparin distribution
largely confined to circulation